The effect of 17β-estradiol and α-tocopherol on the oxidation of LDL cholesterol from postmenopausal women and the minor effect of γ-tocopherol and melatonin

被引:20
作者
Arteaga, E
Rojas, A
Villaseca, P
Bianchi, M
机构
[1] Pontificia Univ Catolica Chile, Fac Med, Dept Endocrinol, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Obstet & Gynecol, Santiago, Chile
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2000年 / 7卷 / 02期
关键词
antioxidants; estradiol; lipid peroxidation; melatonin; alpha-tocopherol; gamma-tocopherol;
D O I
10.1097/00042192-200007020-00007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Estrogens have a potent antioxidant effect on low-density lipoprotein (LDL) cholesterol in vitro and in vivo. A variety of compounds with antioxidant properties, such as vitamins and other hormones, also have been recommended in clinical practice to prevent several diseases related to oxidation. The aim of this study was to compare the antioxidant potency of estradiol (E-2), the liposoluble vitamin E (both, alpha- and gamma-tocopherol), and melatonin. Design: LDL was isolated by ultracentrifugation from the plasma of 11 healthy, untreated postmenopausal women. Aliquots containing 0.5 mg of LDL protein were incubated for 4 h with 15 mu M of CuSO4 to induce oxidative stress and with one of the four compounds studied: E-2, alpha-tocopherol, gamma-tocopherol, or melatonin in doses of 0, 5, 15, 50, and 500 mu M and 1 and 2 mM. Malondialdehyde (MDA) was measured as a marker of LDL oxidation, Results: E-2 induced a dose-dependent decrease in MDA concentration (nmol/mg protein). MDA values were significantly different as compared with baseline at 5 mu M of E-2 (F = 47.17; p < 0.0001), Alpha-tocopherol, gamma-tocopherol, and melatonin also showed a significant decrease in MDA concentration but to a lesser degree. The reduction of MDA reached statistical significance at 50 mu M with alpha-tocopherol, 500 mu M with melatonin, and 1 mM with gamma-tocopherol. The antioxidant effect also reached a plateau at concentrations of 50 mu M of E-2 and 1 mM of alpha-tocopherol; gamma-tocopherol and melatonin did not reach a plateau at any dose tested. Conclusions: The antioxidant potency of E-2 in vitro is at least 10-100 times greater than alpha- and gamma-tocopherol and melatonin. Whether this finding implies a better performance of E-2 as a protective agent against oxidation-related diseases remains to be determined. (Menopause 2000;7:112-116. (C) 2000, The North American Menopause Society.).
引用
收藏
页码:112 / 116
页数:5
相关论文
共 18 条
[1]   Antioxidant role of melatonin in lipid peroxidation of human LDL [J].
Abuja, PM ;
Liebmann, P ;
Hayn, M ;
Schauenstein, K ;
Esterbauer, H .
FEBS LETTERS, 1997, 413 (02) :289-293
[2]  
Arteaga E, 1998, MENOPAUSE, V5, P16
[3]  
Arteaga E, 1998, REV MED CHILE, V126, P481
[4]  
ARTEAGA E, 1998, J BR MENOPAUSE SO S1, V4, P22
[5]   MELATONIN FOR TREATMENT OF CHRONIC REFRACTORY SARCOIDOSIS [J].
CAGNONI, ML ;
LOMBARDI, A ;
CERINIC, MM ;
DEDOLA, GL ;
PIGNONE, A .
LANCET, 1995, 346 (8984) :1229-1230
[6]   EFFECT OF ANTIOXIDANTS ON OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
PUHL, H ;
DIEBERROTHENEDER, M ;
WAEG, G ;
RABL, H .
ANNALS OF MEDICINE, 1991, 23 (05) :573-581
[7]   BINDING-SITE ON MACROPHAGES THAT MEDIATES UPTAKE AND DEGRADATION OF ACETYLATED LOW-DENSITY LIPOPROTEIN, PRODUCING MASSIVE CHOLESTEROL DEPOSITION [J].
GOLDSTEIN, JL ;
HO, YK ;
BASU, SK ;
BROWN, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (01) :333-337
[8]   The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data (vol 123, pg 860, 1995) [J].
Jha, P ;
Flather, M ;
Lonn, E ;
Farkouh, M ;
Yusuf, S .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (10) :934-934
[9]   Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease [J].
Mosca, L ;
Rubenfire, M ;
Mandel, C ;
Rock, C ;
Tarshis, T ;
Tsai, A ;
Pearson, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) :392-399
[10]  
PALINSKI W, 1993, NEW HORIZONS CORONAR